PODER Familiar: Health Promotion for Latino Families of Children With IDD
PODER Familiar: A Health Promotion Intervention for Latino Families of Children With Intellectual and Developmental Disabilities
University of Texas at Austin
90 participants
Jan 17, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to test a culturally tailored health promotion intervention for children with IDD and their families. First investigators will conduct a single group design pilot study of a health promotion intervention, followed by second, a small-scale randomized control trial (RCT). of the intervention with Latino parents of children with intellectual and developmental disabilities (IDD) in the Chicago, Illinois and Austin, Texas areas. The following research questions will be addressed: Question 1: What is the appropriate content, dosage, and delivery method of the intervention? Question 2: What is the feasibility and acceptability of the intervention? Question 3: Do participants improve between pre and post-test on outcome measures both in the one group design and compared to the control group in the RCT? Parents will receive 10 weekly remote sessions on health promotion content delivered by parent mentors called promotoras. Parents and children will attend 3 multi-family group workshops in-person that will provide demonstrations and interactive activities.
Eligibility
Inclusion Criteria7
- Parent/Caregiver
- identify as parent or primary family caregiver
- years of age or older
- Identify as Latino/a or of Latin American Descent
- have a child with IDD between 6 and 17 years of age Child with IDD
- between 6 and 17 years old
- the child has a diagnosis of autism spectrum disorder, Down syndrome or intellectual disability
Exclusion Criteria1
- Child uses mobility aid
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Educational intervention designed to improve healthy behaviors of families of children with intellectual and developmental disabilities.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05713617